Serial neurotech founder Hamed Bahmani has unveiled Insellar, a stealth startup exploring deep-brain stimulation of neuroendocrine systems as a new approach to treating severe, treatment-resistant depression.

Rune Labs is translating passive digital data into clinically actionable insights, using neuroscience-grounded validation to make digital phenotyping work in real-world neurology.

uCat is developing a software layer that turns high-bandwidth BCI signals into speech and embodied interaction, using virtual environments to restore agency and enable richer forms of communication and control.

Neurotech startups face long timelines and high uncertainty. PsyMed Ventures is betting early, backing neuroscience founders with capital, domain expertise, and a new program designed to help academics make the leap into entrepreneurship.